Inventor · disambiguated record
Silvia Paoletta
Also filed as: PAOLETTA SILVIA
7 granted patents·4 pending applications·9 citations·filing 2017–2024
77Inventor score
Top patents by PatentIndex Score
11 records- 0189US10954241B2Heterocyclic compounds as ret kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Mar 23, 2021·3 cites·29 claims
- 0288US10844067B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Nov 24, 2020·4 cites·27 claims
- 0387US11548896B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2021·Granted Jan 10, 2023·1 cites·30 claims
- 0485US11661423B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2020·Granted May 30, 2023·1 cites·24 claims
- 0585US2025236624A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 0678US2023339954A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Application pending·0 cites
- 0776US2024116938A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
- 0864US2024252506A1Compounds for treatment of bacterial infectionHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0960US11377443B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2020·Granted Jul 5, 2022·0 cites·8 claims
- 1056US10696666B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2017·Granted Jun 30, 2020·0 cites·8 claims
- 1142US10647704B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2017·Granted May 12, 2020·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →